ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 189 filers reported holding ARRAY BIOPHARMA INC in Q2 2017. The put-call ratio across all filers is 0.70 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $9,331,000 | +33.0% | 382,739 | -22.3% | 0.07% | +22.2% |
| Q4 2018 | $7,017,000 | +23.3% | 492,427 | +31.5% | 0.05% | +45.9% |
| Q3 2018 | $5,693,000 | +11.5% | 374,570 | +23.1% | 0.04% | +12.1% |
| Q2 2018 | $5,104,000 | +12.3% | 304,200 | +9.2% | 0.03% | -8.3% |
| Q1 2018 | $4,545,000 | +62.6% | 278,488 | +27.6% | 0.04% | +89.5% |
| Q4 2017 | $2,795,000 | +34.6% | 218,328 | +29.3% | 0.02% | +26.7% |
| Q3 2017 | $2,077,000 | +61.0% | 168,843 | +9.5% | 0.02% | +66.7% |
| Q2 2017 | $1,290,000 | – | 154,170 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Advisory Services Network, LLC | 3,442 | $159,000 | 0.01% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |